Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation

Background: Awareness about the importance of implementing DPYD pharmacogenetics in clinical practice to prevent severe side effects related to the use of fluoropyrimidines has been raised over the years. Since 2012 at the National Cancer Institute, CRO-Aviano (Italy), a diagnostic DPYD genotyping s...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	A. Bignucolo, E. De Mattia, R. Roncato, E. Peruzzi, L. Scarabel, M. D’Andrea, F. Sartor, G. Toffoli, E. Cecchin
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2023-05-01
Ráidu:	Frontiers in Pharmacology
Fáttát:	pharmacogenetics DPYD implementation genotyping phenotyping CDSS
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1199462/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!